# Xenon Pharmaceuticals Inc (XENE) XENE's price has declined despite reaching a 52-week high, attributed to negative sentiment and reduced social engagement, overriding positive study data and portfolio inclusion mentions. Social dominance is up significantly, indicating increased discussion. ### About Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders. Xenon Pharmaceuticals Inc uses the ticker $XENE for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Xenon Pharmaceuticals Inc (XENE) trading volume is up 26.39% from the previous week. - Xenon Pharmaceuticals Inc (XENE) social dominance is up 1173.91% from the previous week. - Xenon Pharmaceuticals Inc (XENE) Galaxy Score™ is up 150% from the previous month. - Xenon Pharmaceuticals Inc (XENE) creators is up 64% from the previous month. - Xenon Pharmaceuticals Inc (XENE) engagements is up 184.18% from the previous week. - Xenon Pharmaceuticals Inc (XENE) mentions is up 38.26% from the previous week. - Xenon Pharmaceuticals Inc (XENE) posts created is up 58.33% from the previous week. ### Price: $41.50  [Price 24-Hour Time-Series Raw Data](/topic/$xene/time-series/close.tsv) Despite reaching a 52-week high, XENE's price has declined. This is attributed to negative sentiment and reduced social engagement, which have outweighed positive study data and portfolio inclusion mentions. The significant increase in social dominance suggests a surge in discussion around the stock. 24-Hour: -0.34% 7-Day: 0.24% 30-Day: 3.75% 1-Year High: $46.10 on 2025-12-22 1-Year Low: $28.20 on 2025-04-08 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/$xene/time-series/alt_rank.tsv) Xenon Pharmaceuticals Inc (XENE) is currently AltRank #827 based on combined combined social and market metrics Daily Average: [---] [--] Week: [---] [---] [--] Month: [---] [----] [--] Months: [---] [----] [--] Year: [---] [------] 1-Year High: [-----] on 2025-07-27 1-Year Low: [--] on 2025-04-18 ### Galaxy Score: [--]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$xene/time-series/galaxy_score.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] +14 [--] Month: [--] +36 [--] Months: [--] [---] [--] Year: [--] +30 1-Year High: [--] on 2025-08-04 1-Year Low: [--] on 2025-08-28 ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$xene/time-series/interactions.tsv) Current Value: [------] Daily Average: [-----] [--] Week: [------] +184% [--] Month: [-------] -7.60% [--] Months: [---------] -39% [--] Year: [---------] -2.70% 1-Year High: [-------] on 2025-07-18 1-Year Low: [---] on 2026-01-04 Engagements by network (24h): Reddit: [--] YouTube: [--] News: [--] X: [------] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$xene/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] [--] Week: [---] +38% [--] Month: [---] +29% [--] Months: [-----] -35% [--] Year: [-----] +53% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-09-27 Mentions by network (24h): Reddit: [--] YouTube: [--] News: [--] X: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$xene/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Xenon Pharmaceuticals Inc (XENE) in the last [--] hours which is up 15% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [--] +55% [--] Month: [---] +64% [--] Months: [---] -69% [--] Year: [-----] +43% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-04-24 The most influential creators that mention Xenon Pharmaceuticals Inc in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | [--] | [------] | [--] | [-----] | | [@Andre_AGTC](/creator/twitter/Andre_AGTC) | [--] | [-----] | [--] | [-----] | | [@WolfOfPathogens](/creator/twitter/WolfOfPathogens) | [--] | [--] | [--] | [---] | | [@Biotech2k1](/creator/twitter/Biotech2k1) | [--] | [------] | [--] | [---] | | [@DeepSouthDoctor](/creator/twitter/DeepSouthDoctor) | [--] | [-----] | [--] | [--] | | [@inshatters1](/creator/twitter/inshatters1) | [--] | [--] | [--] | [--] | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | [--] | [--] | [--] | [--] | | [@OptionsFlowBoss](/creator/twitter/OptionsFlowBoss) | [--] | [-----] | [--] | [--] | | [@Fredbenz0](/creator/twitter/Fredbenz0) | [--] | [-----] | [--] | [--] | | [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | [--] | [---] | [--] | [--] | [View More](/list/creators/$xene/100) ### Sentiment: 91%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$xene/time-series/sentiment.tsv) Current Value: 91% Daily Average: 84% [--] Week: 100% no change [--] Month: 82% -4% [--] Months: 82% +4% [--] Year: 82% no change 1-Year High: 100% on 2025-03-19 1-Year Low: 30% on 2025-04-29 Most Supportive Themes: - Seizure and Epilepsy Treatments: (50%) Xenon Pharmaceuticals Inc. is developing treatments for neurological disorders, specifically epilepsy and seizures. - Portfolio Inclusion: (30%) Investors are adding Xenon Pharmaceuticals Inc. to their portfolios, indicating confidence in its future prospects. - Strength Meter Maps: (20%) Xenon Pharmaceuticals Inc. is being mentioned in the context of strength meter maps, suggesting its performance is being tracked within broader market analyses. Most Critical Themes: - Negative Sentiment and Declining Social Engagement: (100%) A prevailing negative sentiment and a decrease in social media engagement are identified as potential reasons for the recent stock price dip. ### Social Dominance: 0.00463%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$xene/time-series/social_dominance.tsv) Current Value: 0.00463% Daily Average: 0.00833% [--] Week: 0.029% +0.027% [--] Month: 0.013% +0.0071% [--] Months: 0.013% +0.0011% [--] Year: 0.013% +0.0052% 1-Year High: 0.035% on 2025-06-28 1-Year Low: 0.0021% on 2025-09-27 ### Market Dominance: 0.00363%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$xene/time-series/market_dominance.tsv) Current Value: 0.00363% Daily Average: 0% 1-Year High: 0.148% on 2026-02-06 1-Year Low: 0.00363% on 2026-02-14 ### Market Cap: $3,205,367,207  [Market Cap 24-Hour Time-Series Raw Data](/topic/$xene/time-series/market_cap.tsv) Current Value: $3,205,367,207 Daily Average: $2,869,277,297 [--] Week: $3,205,367,207 +0.24% [--] Month: $3,205,367,207 +1.80% [--] Months: $3,205,367,207 +9.90% [--] Year: $3,205,367,207 +8.10% 1-Year High: $3,560,832,230 on 2025-12-22 1-Year Low: $2,160,803,555 on 2025-04-08 ### Top Xenon Pharmaceuticals Inc Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a" [X Link](https://x.com/BiopharmIQ/status/2022703288546922772) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-14T16:03Z 28.9K followers, [----] engagements "$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona Lasofoxifene Fulvestrant ($1.2B annual) 87% Instit huge time arbtitrage oppor" [X Link](https://x.com/WolfOfPathogens/status/2022327290168782905) [@WolfOfPathogens](/creator/x/WolfOfPathogens) 2026-02-13T15:09Z [--] followers, [---] engagements "$CMPS MC 570M 6.5M diagnosed TRD pts / 3M in US TAM $6.7B+ by [----] $CMPS (COMP360) ph3 TRD data in Q1'26 NDA in H2'26 Single-dose durability vs. Spravato repeat dosing $JNJ Spravato 2019: FDA approval for TRD 2025: $1.7B revenue (blockbuster) 60% growth in q4 vs [----] @KingachillesE $CMPS will combine 9w data (Part A) and 26w data (Part B). Practically two readouts at once so it might take a bit longer But on the other side $XENE had a history running slower than expected so who knows Added to $CMPS at [----] today at close. Hope is not too early @KingachillesE $CMPS will combine 9w data (Part" [X Link](https://x.com/Andre_AGTC/status/2022318670702153887) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-13T14:35Z [----] followers, [----] engagements "@KingachillesE $CMPS will combine 9w data (Part A) and 26w data (Part B). Practically two readouts at once so it might take a bit longer But on the other side $XENE had a history running slower than expected so who knows Added to $CMPS at [----] today at close. Hope is not too early" [X Link](https://x.com/Andre_AGTC/status/2022081100156379167) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-12T22:51Z [----] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
XENE's price has declined despite reaching a 52-week high, attributed to negative sentiment and reduced social engagement, overriding positive study data and portfolio inclusion mentions. Social dominance is up significantly, indicating increased discussion.
Xenon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders.
Xenon Pharmaceuticals Inc uses the ticker $XENE for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
Despite reaching a 52-week high, XENE's price has declined. This is attributed to negative sentiment and reduced social engagement, which have outweighed positive study data and portfolio inclusion mentions. The significant increase in social dominance suggests a surge in discussion around the stock.
24-Hour: -0.34% 7-Day: 0.24% 30-Day: 3.75%
1-Year High: $46.10 on 2025-12-22
1-Year Low: $28.20 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Xenon Pharmaceuticals Inc (XENE) is currently AltRank #827 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [---]
[--] Month: [---] [----]
[--] Months: [---] [----]
[--] Year: [---] [------]
1-Year High: [-----] on 2025-07-27
1-Year Low: [--] on 2025-04-18
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +14
[--] Month: [--] +36
[--] Months: [--] [---]
[--] Year: [--] +30
1-Year High: [--] on 2025-08-04
1-Year Low: [--] on 2025-08-28
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [------] +184%
[--] Month: [-------] -7.60%
[--] Months: [---------] -39%
[--] Year: [---------] -2.70%
1-Year High: [-------] on 2025-07-18
1-Year Low: [---] on 2026-01-04
Engagements by network (24h): Reddit: [--] YouTube: [--] News: [--] X: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +38%
[--] Month: [---] +29%
[--] Months: [-----] -35%
[--] Year: [-----] +53%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-27
Mentions by network (24h): Reddit: [--] YouTube: [--] News: [--] X: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Xenon Pharmaceuticals Inc (XENE) in the last [--] hours which is up 15% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +55%
[--] Month: [---] +64%
[--] Months: [---] -69%
[--] Year: [-----] +43%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-24
The most influential creators that mention Xenon Pharmaceuticals Inc in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @Andre_AGTC | [--] | [-----] | [--] | [-----] |
| @WolfOfPathogens | [--] | [--] | [--] | [---] |
| @Biotech2k1 | [--] | [------] | [--] | [---] |
| @DeepSouthDoctor | [--] | [-----] | [--] | [--] |
| @inshatters1 | [--] | [--] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @OptionsFlowBoss | [--] | [-----] | [--] | [--] |
| @Fredbenz0 | [--] | [-----] | [--] | [--] |
| @TheOptionsBull2 | [--] | [---] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 91%
Daily Average: 84%
[--] Week: 100% no change
[--] Month: 82% -4%
[--] Months: 82% +4%
[--] Year: 82% no change
1-Year High: 100% on 2025-03-19
1-Year Low: 30% on 2025-04-29
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00463%
Daily Average: 0.00833%
[--] Week: 0.029% +0.027%
[--] Month: 0.013% +0.0071%
[--] Months: 0.013% +0.0011%
[--] Year: 0.013% +0.0052%
1-Year High: 0.035% on 2025-06-28
1-Year Low: 0.0021% on 2025-09-27
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00363%
Daily Average: 0%
1-Year High: 0.148% on 2026-02-06
1-Year Low: 0.00363% on 2026-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,205,367,207
Daily Average: $2,869,277,297
[--] Week: $3,205,367,207 +0.24%
[--] Month: $3,205,367,207 +1.80%
[--] Months: $3,205,367,207 +9.90%
[--] Year: $3,205,367,207 +8.10%
1-Year High: $3,560,832,230 on 2025-12-22
1-Year Low: $2,160,803,555 on 2025-04-08
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, [----] engagements
"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona Lasofoxifene Fulvestrant ($1.2B annual) 87% Instit huge time arbtitrage oppor"
X Link @WolfOfPathogens 2026-02-13T15:09Z [--] followers, [---] engagements
"$CMPS MC 570M 6.5M diagnosed TRD pts / 3M in US TAM $6.7B+ by [----] $CMPS (COMP360) ph3 TRD data in Q1'26 NDA in H2'26 Single-dose durability vs. Spravato repeat dosing $JNJ Spravato 2019: FDA approval for TRD 2025: $1.7B revenue (blockbuster) 60% growth in q4 vs [----] @KingachillesE $CMPS will combine 9w data (Part A) and 26w data (Part B). Practically two readouts at once so it might take a bit longer But on the other side $XENE had a history running slower than expected so who knows Added to $CMPS at [----] today at close. Hope is not too early @KingachillesE $CMPS will combine 9w data (Part"
X Link @Andre_AGTC 2026-02-13T14:35Z [----] followers, [----] engagements
"@KingachillesE $CMPS will combine 9w data (Part A) and 26w data (Part B). Practically two readouts at once so it might take a bit longer But on the other side $XENE had a history running slower than expected so who knows Added to $CMPS at [----] today at close. Hope is not too early"
X Link @Andre_AGTC 2026-02-12T22:51Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$xene